We are live on ! Find out more
ADEF

Adams Diversified Equity Fund Portfolio holdings

AUM $3.27B
1-Year Est. Return 45.57%
This Fund
S&P 500
This Quarter Est. Return
+5.17%
1 Year Est. Return
+45.57%
3 Year Est. Return
+150.13%
5 Year Est. Return
+214.77%
10 Year Est. Return
+830.6%
AUM
$1.88B
AUM Growth
+$66.4M
Cap. Flow
-$16.8M
Cap. Flow %
-0.89%
Top 10 Hldgs %
27%
Holding
229
New
10
Increased
14
Reduced
141
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 17.87%
3 Healthcare 13.16%
4 Consumer Discretionary 9.88%
5 Industrials 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGNX icon
201
Regenxbio
RGNX
$620M
$108K 0.01%
2,100
-2,200
-51% -$110K
BSTC
202
DELISTED
BioSpecifics Technologies Corp.
BSTC
$107K 0.01%
1,800
-1,200
-40% -$75.5K
PAHC icon
203
Phibro Animal Health
PAHC
$1.47B
$105K 0.01%
3,300
-1,500
-31% -$47K
MTRX icon
204
Matrix Service
MTRX
$326M
$103K 0.01%
5,100
-5,700
-53% -$112K
CMRE icon
205
Costamare
CMRE
$1.88B
$102K 0.01%
19,900
-22,400
-53% -$123K
GTN icon
206
Gray Television
GTN
$415M
$100K 0.01%
6,100
-7,000
-53% -$139K
PRTY
207
DELISTED
Party City Holdco Inc.
PRTY
$97K 0.01%
13,300
-14,800
-53% -$113K
MTX icon
208
Minerals Technologies
MTX
$2.36B
$96K 0.01%
1,800
-2,100
-54% -$123K
AMKR icon
209
Amkor Technology
AMKR
$12.4B
$95K 0.01%
12,800
-14,300
-53% -$112K
AMAG
210
DELISTED
AMAG Pharmaceuticals
AMAG
$95K 0.01%
9,500
-2,300
-19% -$24.8K
LCI
211
DELISTED
Lannett Company, Inc.
LCI
$93K ﹤0.01%
3,850
-2,450
-39% -$64.7K
SUPN icon
212
Supernus Pharmaceuticals
SUPN
$2.59B
$89K ﹤0.01%
2,700
-3,000
-53% -$103K
MKSI icon
213
MKS Inc
MKSI
$20.1B
$86K ﹤0.01%
1,100
-1,300
-54% -$110K
ENTA icon
214
Enanta Pharmaceuticals
ENTA
$366M
$84K ﹤0.01%
1,000
-1,300
-57% -$117K
KYNB
215
Kyntra Bio
KYNB
$27.2M
$81K ﹤0.01%
72
-84
-54% -$91.9K
CRZO
216
DELISTED
Carrizo Oil & Gas Inc
CRZO
$81K ﹤0.01%
8,100
-8,900
-52% -$102K
DO
217
DELISTED
Diamond Offshore Drilling
DO
$76K ﹤0.01%
8,600
-9,600
-53% -$92K
EBS icon
218
Emergent Biosolutions
EBS
$373M
$72K ﹤0.01%
1,500
-1,700
-53% -$81.5K
CCXI
219
DELISTED
ChemoCentryx, Inc.
CCXI
$69K ﹤0.01%
7,400
-8,300
-53% -$96.1K
VNDA icon
220
Vanda Pharmaceuticals
VNDA
$307M
$42K ﹤0.01%
3,000
-3,500
-54% -$55.7K
AMGN icon
221
Amgen
AMGN
$208B
-75,700
Closed -$14.4M
BR icon
222
Broadridge
BR
$17.8B
-67,300
Closed -$6.98M
CNC icon
223
Centene
CNC
$30.7B
-131,800
Closed -$7M
LUV icon
224
Southwest Airlines
LUV
$22B
-139,000
Closed -$7.21M
MPC icon
225
Marathon Petroleum
MPC
$92.4B
-167,525
Closed -$10M

Similar funds

Adams Diversified Equity Fund's Q2 2019 Portfolio in Review

As of Q2 2019, Adams Diversified Equity Fund held 229 positions worth $1.88B, up 3.7% from $1.82B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Adams Diversified Equity Fund's Q2 2019 filing shows 10 new, 14 increased, 141 reduced and 9 closed positions. Its largest new stake was T. Rowe Price: 167,400 shares worth $18.4M. The largest sale was Berkshire Hathaway Class B, an estimated $22.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Adams Diversified Equity Fund's largest Q2 2019 buy was T. Rowe Price: 167,400 shares worth $18.4M.
  • Adams Diversified Equity Fund added most to Coca-Cola in Q2 2019, an estimated $18.2M increase.
  • Adams Diversified Equity Fund's biggest Q2 2019 reduction was Berkshire Hathaway Class B, cutting an estimated $22.9M.
  • Adams Diversified Equity Fund fully exited Amgen in Q2 2019, selling an estimated $14.4M.
  • Adams Diversified Equity Fund's ten largest holdings make up 27% of its $1.88B portfolio in Q2 2019.
  • Adams Diversified Equity Fund opened 10 new positions and closed 9 in Q2 2019.
  • Adams Diversified Equity Fund's portfolio value rose 3.7% quarter-over-quarter to $1.88B.

Based on Adams Diversified Equity Fund's 13F filing for Q2 2019, filed 29 Jul 2019.